Dibenzo(a,i)pyrene|CAS 191-30-0|DC Chemicals

Cas No.:	191-30-0
Chemical Name:	Dibenzodef,pchrysene
Synonyms:	Dibenzo[def,p]chrysene;DIBENZO(A,I)PYRENE;1,2,3,4-DIBENZPYRENE;1,2,4,5-DIBENZPYRENE;Dibenz[a,l]pyrene solution;Dibenzo[a,l]pyrene;Dibenzo[a,l]pyrene solution;1,2,9,10-Dibenzopyrene;1,2:3,4-Dibenzopyrene;4,5,6,7-Dibenzpyrene;Dibenzpyrene;Dibenzo(a,l)pyrene;dibenzocrysene;DBC;DBC-d7;db(a,1)p;Db(a,l)p;NSC 90324;ba51-090462;NSC 90324-d7;Ba 51-090462-d7;DIBENZ(A,I)PYRENE;Ba 51-090462;AKOS024319580;Dibenzo[a,l]pyrene 10 microg/mL in Cyclohexane;Dibenzo(a,d)pyrene;DB(a,l)P;Dibenzo(def,p)chrysene;Dibenzo[a,l]pyrene, BCR(R) certified Reference Material;Dibenzo[d,f,p]chrysene;UNII-G3X629VE4A;1ST000303;191-30-0;hexacyclo[10.10.2.02,7.08,24.015,23.017,22]tetracosa-1(23),2,4,6,8,10,12(24),13,15,17,19,21-dodecaene;1,4-Dibenzopyrene;BA 51-090462;dibenz[a,l]pyrene;CCRIS 210;1,2:9,10-Dibenzopyrene;JNTHRSHGARDABO-UHFFFAOYSA-N;Dibenzo[a,l]pyrene 10 microg/mL in Acetonitrile;NSC-90324;Q26840756;Dibenzo[a,d]pyrene;2-DECYLDODECANOICACID;Dibenzo(d,e,f,p)chrysene;naphtho[1,2,3,4-pqr]tetraphene;1,3,4-Dibenzpyrene;FT-0666414;EINECS 205-886-4;CHEBI:35861;NSC90324;DTXSID9059753;4,5:6,7-Dibenzpyrene;BRN 2054068;4,6,7-Dibenzpyrene;WLN: L D66 K666 B6 2AB A & J;G3X629VE4A;1,2,3,4-Dibenzpyrene;DIBENZO(A,L)PYRENE [HSDB];Dibenzo[a,l]pyrene, vial of 25 mg;2,3:4,5-Dibenzopyrene;1,9,10-Dibenzopyrene;DIBENZO(A,L)PYRENE;DIBENZO(A,L)PYRENE [IARC];NS00019597;HSDB 4029;2,3:4,5-Dibenzpyrene;J-012363;C19174
SMILES:	C1=CC2=CC3=C4C5=C(C=CC=C5C6=CC=CC=C6C4=C2C=C1)C=C3
Formula:	C₂₄H₁₄
M.Wt:	302.36796
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.